Drug Shortage Report for JAMP METHIMAZOLE

Last updated on 2023-01-31 History
Report ID 154919
Drug Identification Number 02490625
Brand name JAMP METHIMAZOLE
Common or Proper name Methimazole Tablets, USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) METHIMAZOLE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code H03BB
ATC description ANTITHYROID PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-02-09
Actual start date 2022-04-30
Estimated end date 2023-02-10
Actual end date 2023-01-27
Shortage status Resolved
Updated date 2023-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-01-31 French Compare
v13 2023-01-31 English Compare
v12 2023-01-10 French Compare
v11 2023-01-10 English Compare
v10 2022-11-09 French Compare
v9 2022-11-09 English Compare
v8 2022-09-16 French Compare
v7 2022-09-16 English Compare
v6 2022-06-13 French Compare
v5 2022-06-13 English Compare
v4 2022-03-08 French Compare
v3 2022-03-08 English Compare
v2 2022-02-14 French Compare
v1 2022-02-14 English Compare

Showing 1 to 14 of 14